- Home
- CHEF vs IBRX Comparison
CHEF vs IBRX Comparison
Compare CHEF & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEF
- IBRX
- Stock Information
- Founded
- CHEF 1985
- IBRX 2014
- Country
- CHEF United States
- IBRX United States
- Employees
- CHEF N/A
- IBRX N/A
- Industry
- CHEF Food Distributors
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHEF Consumer Discretionary
- IBRX Health Care
- Exchange
- CHEF Nasdaq
- IBRX Nasdaq
- Market Cap
- CHEF 2.2B
- IBRX 2.6B
- IPO Year
- CHEF 2011
- IBRX N/A
- Fundamental
- Price
- CHEF $52.70
- IBRX $2.82
- Analyst Decision
- CHEF Strong Buy
- IBRX Strong Buy
- Analyst Count
- CHEF 6
- IBRX 4
- Target Price
- CHEF $66.00
- IBRX $12.19
- AVG Volume (30 Days)
- CHEF 722.2K
- IBRX 6.4M
- Earning Date
- CHEF 04-30-2025
- IBRX 03-03-2025
- Dividend Yield
- CHEF N/A
- IBRX N/A
- EPS Growth
- CHEF 50.69
- IBRX N/A
- EPS
- CHEF 1.32
- IBRX N/A
- Revenue
- CHEF $3,794,212,000.00
- IBRX $14,745,000.00
- Revenue This Year
- CHEF $7.95
- IBRX $753.44
- Revenue Next Year
- CHEF $7.37
- IBRX $174.29
- P/E Ratio
- CHEF $40.05
- IBRX N/A
- Revenue Growth
- CHEF 10.50
- IBRX 2270.58
- 52 Week Low
- CHEF $31.96
- IBRX $2.28
- 52 Week High
- CHEF $66.51
- IBRX $10.53
- Technical
- Relative Strength Index (RSI)
- CHEF 31.58
- IBRX 42.67
- Support Level
- CHEF $60.55
- IBRX $2.70
- Resistance Level
- CHEF $62.85
- IBRX $3.16
- Average True Range (ATR)
- CHEF 2.39
- IBRX 0.29
- MACD
- CHEF -1.59
- IBRX -0.04
- Stochastic Oscillator
- CHEF 5.50
- IBRX 9.76
About CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. The Chefs' Warehouse operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, mid and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos and speciality food stores.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.